Search

everythinglearnresearchcommunity

for

Search:↓

About 61% of women who had COVID-19 experienced hair loss afterward.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Kenogen increases with hair loss in women.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Using both platelet-rich plasma and minoxidil together gives the best results for hair growth in male rats with hair loss.

COVID-19 infection can significantly cause temporary hair loss.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

The model accurately simulates human hair growth and hair loss patterns.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Monocytes might be linked to hair loss after COVID-19.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Understand the cause of hair loss and consult a professional for the best treatment.